文献速递消化内镜消化道肿瘤与早癌

无黏膜下注射冷圈套息肉切除术治疗大无蒂锯齿状病变的安全性与有效性:前瞻性研究

Safety and Efficacy of Cold Snare Polypectomy Without Submucosal Injection for Large Sessile Serrated Lesions: A Prospective Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-11-02

该前瞻性研究纳入300例患者共474个≥10 mm的无蒂锯齿状病变,采用无黏膜下注射的冷圈套息肉切除术治疗,中位直径14 mm,22%行分块切除,术后切缘活检仅1例(0.2%)残留锯齿状组织,即刻出血8例(3%),无迟发出血,中位随访7个月未发现局部复发。

要点

  • 无黏膜下注射CSP可用于≥10 mm SSL,整块或分块切除均可行
  • 术后切缘活检残留锯齿状组织仅0.2%,即刻出血3%,无迟发出血
  • 中位7个月随访未检出局部复发,但随访时间较短

核心结论

  • 无黏膜下注射的冷圈套息肉切除术是治疗≥10 mm无蒂锯齿状病变安全有效的方法。

主要发现

  • 所有病变均成功切除,中位直径14 mm,106个(22%)病变行分块CSP。
  • 术后切缘活检仅1例(0.2%)发现残留锯齿状组织。
  • 即刻出血8例(3%),无迟发出血,无论是否使用抗血栓药物。
  • 中位随访7个月,对384个病变(81%)行监测结肠镜,未检出局部复发。

关键数值与推荐

  • SSL定义≥10 mm;CSP前使用靛胭脂染色和/或图像增强内镜 delineate 边界。
  • 整块切除困难时行分块CSP;术后从息肉切除缺损边缘取活检确认完全切除。

临床怎么用

  • 对于≥10 mm的SSL,可考虑无黏膜下注射的CSP作为治疗选择。
  • 分块CSP可用于整块切除困难的病例,术后切缘活检有助于确认切除完整性。

局限性

  • 中位随访仅7个月,不足以评估长期局部复发。
  • 单臂前瞻性研究,无对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Cold snare polypectomy (CSP) has become the standard resection method for small colorectal polyps (<10 mm). Sessile serrated lesions (SSL) have low prevalence of advanced histology irrespective of size, and thus could be amenable to CSP. In this study, we evaluated the safety and efficacy of CSP for SSLs ≥10 mm. METHODS: Between November 2018 and January 2020, we prospectively enrolled 300 consecutive patients who underwent CSP for 474 SSLs ≥10 mm. To delineate SSL borders, indigo carmine chromoendoscopy and/or image-enhanced endoscopy was conducted. Piecemeal CSP (pCSP) was performed in cases where en-bloc resection was difficult. Biopsy specimens were obtained from the margins of the post-polypectomy defect to confirm complete resection. Surveillance colonoscopy was performed to screen for local recurrence. RESULTS: All lesions were successfully resected using CSP without submucosal injection. The median diameter of the resected lesions was 14 mm, and pCSP was used to resect 106 (22%) lesions. Post-polypectomy biopsies revealed residual serrated tissue in only one case (0.2%). Adverse events included immediate bleeding in 8 (3%) patients; no delayed bleeding events occurred, irrespective of the use of antithrombotic drugs. During a 7-month median follow-up period, surveillance colonoscopies were performed for 384 lesions (81%), and no local recurrences were detected. CONCLUSIONS: CSP without submucosal injection is a safe and effective treatment for SSLs ≥10 mm. UMIN Clinical Trials, Number: UMIN000034763.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Kimoto Y, Sakai E, Inamoto R, et al. Safety and Efficacy of Cold Snare Polypectomy Without Submucosal Injection for Large Sessile Serrated Lesions: A Prospective Study. Clin Gastroenterol Hepatol. 2020. PMID: 33152541. doi:10.1016/j.cgh.2020.10.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。